Efficacy & Toxicity
Target Validation
Toxicity Assays
Multi Cancer Screening

Key technology

Inovotion develops new predictive applications for Personalized Medicine, based on our unique patented CAM assay to grow human tumor avatars derived from patient-derived organoids, biopsies, and Circulating Tumoral Cells (CTCs).

 

Key Applications:
- Patient stratification for Clinical Trials
- Drug resistance and biomarker monitoring for managing residual disease in patients during Clinical Trials
- Monitoring molecular profiling, to evaluate clonal evolution and resistance mechanisms.
- Diagnostic tests for individual patients

Residual disease

  • Patient management
  • Response monitoring

Molecular profiling

  • Clonal evolution
  • Resistance mechanisms

Targeted Cancers

Inovotion focuses on breast, prostate, lung, and colorectal cancers.

If you have Personalized Medicine projects, contact us! We are always interested to develop ambitious approaches.